Found 344 matching trials
Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation PHASE1 This is a phase I single center dose escalation study with an extension at ...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
Baricitinib for the Prophylaxis of Graft-Versus-Host Disease After Peripheral Blood Hematopoietic Cell Transplantation PHASE1 In this trial, the investigators will begin to explore the possibility that...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Phase I Clinical Trial to Assess Safety of UV Phototherapy for the Prevention of GVHD Post Allogeneic SCT PHASE1 The primary goal of thos study is to assess safety of Ultraviolet (UV) Phot...
Show More Location
Hadassah Medical Organization
Learn More & Join Trial
Targeted Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation PHASE3 The purpose of this study is to determine the response and toxicity rate of...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
Prevention of Severe Acute Graft-versus-host Disease in Adult Patients Using a daGOAT Model PHASE2 To evaluate the efficacy and safety of ruxolitinib for prophylactic therapy...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
Rifaximin for Infection Prophylaxis in Hematopoietic Stem Cell Transplantation EARLY_PHASE1 Primary purpose of the study is to see if rifaximin can improve the balance...
Show More Location
Children's Healthcare of Atlanta
Learn More & Join Trial
Phase I-II PTCy, Bortezomib and Sitagliptin for Prevention of GvHD Following Allogeneic HSCT PHASE1 Phase I-II studying post transplant cyclophosphamide, bortezomib and sitagl...
Show More Learn More & Join Trial
A Study of Tacrolimus/Methotrexate and Tocilizumab to Prevent Acute Graft-Versus-Host Disease (AGVD) After Allogeneic Hematopoietic Stem Cell Transplant PHASE2 This is a phase II open label trial designed to evaluate the efficacy of Ta...
Show More Location
Froedtert Hospital and the Medical College of Wisconsin
Learn More & Join Trial
Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention PHASE3 This randomized clinical trial studies standard GVHD prophylaxis with tacro...
Show More Location
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Learn More & Join Trial
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant PHASE2 The researchers are doing this study to compare 2 different GVHD prevention...
Show More Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Learn More & Join Trial